On Nov 8, 2021 DeepCure closed a Series A round and raised $40,000,000 from Benon Group Ltd., Morningside Ventures, Sapir Venture Partners, TLV Partners, featuring lead investors Morningside Ventures.

About the company: DeepCure is located at United States, North America.
“Pioneering a new frontier in drug development. DeepCure is building an AI engine for small-molecule drug discovery.”

Company website: http://www.deepcure.ai